4538 Stock Overview
Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceuticals and medical equipment in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
Fuso Pharmaceutical Industries,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,231.00 |
| 52 Week High | JP¥2,363.00 |
| 52 Week Low | JP¥1,841.00 |
| Beta | 0 |
| 1 Month Change | -3.79% |
| 3 Month Change | 0.77% |
| 1 Year Change | 8.88% |
| 3 Year Change | -7.08% |
| 5 Year Change | -9.42% |
| Change since IPO | -77.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4538 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 1.9% | 1.1% | -1.0% |
| 1Y | 8.9% | 3.7% | 27.9% |
Return vs Industry: 4538 exceeded the JP Pharmaceuticals industry which returned 3.7% over the past year.
Return vs Market: 4538 underperformed the JP Market which returned 27.9% over the past year.
Price Volatility
| 4538 volatility | |
|---|---|
| 4538 Average Weekly Movement | 3.0% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4538 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4538's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | n/a | Mikio Toda | www.fuso-pharm.co.jp |
Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceuticals and medical equipment in Japan. The company offers injectables, infusions, and dialysis agents for artificial kidneys, as well as medical equipment and devices.
Fuso Pharmaceutical Industries,Ltd. Fundamentals Summary
| 4538 fundamental statistics | |
|---|---|
| Market cap | JP¥18.88b |
| Earnings (TTM) | JP¥4.87b |
| Revenue (TTM) | JP¥48.61b |
0.0x
P/E Ratio0.0x
P/S RatioIs 4538 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4538 income statement (TTM) | |
|---|---|
| Revenue | JP¥48.61b |
| Cost of Revenue | JP¥33.30b |
| Gross Profit | JP¥15.32b |
| Other Expenses | JP¥10.45b |
| Earnings | JP¥4.87b |
Last Reported Earnings
Mar 31, 2013
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 4538 perform over the long term?
See historical performance and comparison